Skip to main contentSkip to navigationSkip to search
HNSA (, %) SEK
Hansa Biopharma logotype

Increase of number of shares and votes in Hansa Medical AB (publ)

Regulatory information
As previously announced, the board of directors of Hansa Medical AB (publ) has on 26 April 2017, by virtue of authorization by the general meeting on 21 November 2016, resolved on a share issue of 401,000 class C shares. The company’s registered share capital and number of outstanding shares and votes have thus increased during May 2017.

All class C shares are owned by the company. The share issue forms part of the company’s long term incentive program. Prior to delivery of shares to qualifying participants at the end of the program, class C shares will be converted to ordinary shares.

As of May 31, 2017, the total number of registered and outstanding shares of Hansa Medical amounts to 35,455,860 of which 35,054,860 are ordinary shares, with one vote per share, and 401,000 are class C shares, with one tenth of a vote per share. As of May 31, 2017, the number of votes in Hansa Medical amounts to 35,094,960 and the registered share capital amounts to SEK 35,455,860.  

This information is information that Hansa Medical AB (publ) is obliged to make public pursuant to the Financial Instruments Trading Act.The information was submitted for publication, through the agency of the contact person set out below, at 08:00 am CEST on 31 May 2017.